agilon health (AGL) Expected to Announce Earnings on Tuesday

agilon health (NYSE:AGL - Get Free Report) will likely be announcing its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $1.52 billion for the quarter. Investors interested in listening to the company's conference call can do so using this link.

agilon health Price Performance

AGL stock traded up $0.12 during trading on Wednesday, reaching $3.56. 6,624,554 shares of the company were exchanged, compared to its average volume of 5,235,420. The company has a market cap of $1.47 billion, a P/E ratio of -3.79 and a beta of 0.67. agilon health has a 52-week low of $1.50 and a 52-week high of $7.73. The stock's 50 day moving average price is $2.74 and its 200 day moving average price is $3.12. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

Insider Buying and Selling

In related news, Director John William Wulf purchased 45,000 shares of the company's stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares of the company's stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Diana Mckenzie purchased 12,500 shares of the company's stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average cost of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now directly owns 51,319 shares of the company's stock, valued at $117,007.32. The trade was a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 90,000 shares of company stock valued at $198,100. Insiders own 3.20% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Citigroup upgraded shares of agilon health from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Needham & Company LLC assumed coverage on shares of agilon health in a research report on Friday, January 10th. They set a "hold" rating for the company. Macquarie assumed coverage on shares of agilon health in a research report on Monday, December 16th. They set a "neutral" rating and a $3.00 target price for the company. Stifel Nicolaus cut their target price on shares of agilon health from $7.00 to $2.00 and set a "hold" rating for the company in a research report on Tuesday, November 12th. Finally, Sanford C. Bernstein lifted their target price on shares of agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research report on Wednesday, January 15th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $4.03.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.